Skip to content

A prospective, multicenter, randomized controlled study of deferential vessel-sparing modified microsurgical vasoepididymostomy

A prospective, multicenter, randomized controlled study of deferential vessel-sparing modified microsurgical vasoepididymostomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043186
Enrollment
Unknown
Registered
2021-02-08
Start date
2021-02-20
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epididymal obstruction

Interventions

Research Group:deferential vessel-sparing modified microsurgical vasoepididymostomy
control group:deferential vessel-ligated modified microsurgical vasoepididymostomy

Sponsors

The First Affiliated Hospital of Sun Yet-sen University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. The husband and wife are 20-45 years old, and the man had no history of vasectomy; 2. The women have no infertility. The male side had normal hormone level and normal spermatogenic function; 3. The semen routine showed that the semen volume and pH of the subjects with azoospermia were normal; 4. In the subjects with full epididymis and nodule on both sides, vas deferens existed on both sides without dilatation; 5. Subjects with Ag less than 20; 6. Subjects with bilateral epididymal obstruction had no obstruction in other parts of seminal canal; 7. Subjects who had no contraindication before operation; 8. Patients with fertility requirements were diagnosed as obstructive azoospermia and required ve recanalization; 9. The subjects who can follow the procedure understand and answer the research questions correctly, are willing to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who could not establish epididymal body or tail anastomosis during operation; 2. Patients with systemic diseases (bleeding tendency, severe cardiovascular disease, diabetes).

Design outcomes

Primary

MeasureTime frame
Semen Analysis;

Countries

China

Contacts

Public ContactTu Xiangan

The East Division of the First Affiliated Hospital of Sun Yet-sen University

tuxiangan@mail.sysu.edu.cn+86 13822196816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026